Question: if I remember correctly the long acting version of Leronlimab was supposed to completed June 30, 2025. We have not heard a peep about that aspect.
Is it possible that the long acting version could be used in the trials? Or would that have to go through additional testing before being allowed to be used in trials? I’m curious what others think about what the long acting version would be used for? Strictly HIV?? Thoughts??